Retinal ganglion cell (RGC) restoration needs both a map of how RGCs mature and a method to keep them alive and functional in hostile, diseased tissue. Emil’s paper provides the developmental roadmap—tracing human RGC maturation as a continuous trajectory and defining stage-specific programs—while Jon’s paper demonstrates a practical co-treatment strategy that boosts outcomes by sustaining neurotrophic support around donor/host RGCs. Together, they tighten the loop between what mature RGCs should look like and how to help them survive and perform in vivo, informing cell sourcing, bench-marking, and peri-transplant care.
By assembling single-cell RNA-seq across human fetal retina (~weeks 8–27), the study resolves RGC maturation as a continuous process, delineating heterogeneous states along a unified trajectory. This atlas offers clear reference points to gauge in-vitro–derived RGCs and to time interventions against defined maturation windows.
The study tests sustained co-delivery of neurotrophic factors as an adjunct in optic-neuropathy/transplant settings, reporting enhanced outcomes under prolonged support. The work underscores the value of engineering the ocular microenvironment to improve RGC viability and function around transplantation or protection paradigms.